ABOUT

Strategic Opportunities Committee

Responsibilities

Karen Weck President-Elect and Chair
Karen Weck, MD
University of North Carolina

Molecular pathology exists within a rapidly changing environment. The Strategic Opportunities Committee asseses the opportunities and challenges in the molecular pathology profession and other environments external to the organization that affect AMP interests.

The Strategic Opportunities Committee carries out the activities listed below and provides relevant reports and recommendations to the Board of Directors:

  • Assessing trends and activities in the broad environment external to AMP, i.e., "Horizon Scanning";
  • Identifying and assessing external threats that could prevent AMP from attaining its goals;
  • Identifying and assessing external opportunities that can help AMP attain its goals;
  • Identifying organizations for potential relationships that can help AMP attain its goals.

 

Committee Members - 2018-2019

If you are interested in serving on the Strategic Opportunities Committee, please see the various roles available and the responsibilities of each role by clicking here.

Chair (2018-2019)
Karen Weck, MD
University of North Carolina

Member (2018-2019)
Michael Hadjisavas, PhD
QIAGEN

Member (2018-2019)
Robert L. Nussbaum, MD
InVitae

Member (2015-2019)
Ester Stein, BS, MBA
Abbott Molecular Inc.

Board Member (2018-2019)
Annette S. Kim, MD, PhD
Brigham and Women's Hospital

Board Member (2013-2019)
Roger D. Klein, MD, JD
Roger D. Klein, MD JD

 

Advisors

Jill Hagenkord, MD
Color

Terri E Ozegovich, BS MBA
AstraZeneca

 

Christine K. Ward, PhD
Bristol-Myers Squibb

Ex Officio Committee Members

President
Victoria M Pratt, PhD
Indiana University Medical Center

Executive Director (Non-Voting)
Mary Steele Williams, MNA, MT(ASCP)SM

Corporate Partners